Gray Matter Alterations in Adults with Attention-Deficit/Hyperactivity Disorder Identified by Voxel Based Morphometry

Authors:

Abstract
No abstract available
Funding Information
  • National Institute of Mental Health
  • March of Dimes Foundation
  • Mental Illness and Neuroscience Discovery Institute
  • Commonwealth Research Center of the Massachusetts Department of Mental Health
  • National Research Service Award (MH065040-01A1)
  • Peter Livingston
  • Clinical Research Training Program (MH 16259, MH 071535, MH 57934)
  • National Alliance for Research on Schizophrenia and Depression Distinguished Investigator
  • Johnson and Johnson Center for the Study of Psychopathology
  • the National Center for Research Resources (P41RR14075)
  • Janssen Pharmaceutica
  • Alza
  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • McNeil
  • Merck
  • Organon
  • Otsuka
  • Shire
  • NIMH
  • National Institute of Child Health and Human Development
  • Abbott
  • AstraZeneca
  • Celltech
  • Cephalon
  • Eli Lilly and Co.
  • Eisai
  • Forest
  • Glaxo
  • Gliatech
  • Janssen
  • McNeil
  • National Alliance for Research on Schizophrenia and Depression
  • National Institute on Drug Abuse
  • New River
  • Novartis
  • Noven
  • Neurosearch
  • Pfizer
  • Pharmacia
  • The Prechter Foundation
  • Shire
  • The Stanley Foundation
  • UCB Pharma Inc.
  • Wyeth
  • Shire Laboratories Inc.
  • Eli Lilly and Company
  • GlaxoSmith-Kline
  • Janssen Pharmaceutical
  • McNeil Pharmaceutical
  • Novartis Pharmaceuticals
  • Cephalon
  • Pfizer
  • National Institute of Mental Health
  • Eli Lilly
  • Pfizer
  • Shire
  • National Institutes of Health
  • Eli Lilly
  • Shire
  • Pfizer
  • National Institutes of Health

This publication has 80 references indexed in Scilit: